SELENON and myopathy: SELENON (SEPN1)-related myopathies share congenital to early onset of muscle hypotonia and weakness in neck, arm, leg and trunk muscles [[37], [38], [39]], with severity directly correlating with alterations in body mass index [40] suggesting metabolic impairment.